APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Stem Cell Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Stem Cell Drugs Industry Growth and Trends Forecast to 2032

Report ID 174037720131 December 202595 pages

Choose your research edition.

Industry ResearchStem Cell Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Stem Cell Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Stem Cell Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stem Cell Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Stem Cell Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Stem Cell Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Stem Cell Drugs include Anterogen, Chiesi Pharmaceuticals, CORESTEM, Inc, JCR Pharmaceuticals Co., Ltd, MEDIPOST, New York Blood Center, Pharmicell Co., Ltd and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Stem Cell Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Stem Cell Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Stem Cell Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Stem Cell Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Stem Cell Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Stem Cell Drugs Market by Company

Anterogen

Chiesi Pharmaceuticals

CORESTEM, Inc

JCR Pharmaceuticals Co., Ltd

MEDIPOST

New York Blood Center

Pharmicell Co., Ltd

Takeda

Stem Cell Drugs Segment by Type

Adipose-Derived

Cord Blood-Derived

Bone Marrow-Derived

Others

Stem Cell Drugs Segment by Application

Osteoarthritis

Amyotrophic Lateral Sclerosis

Acute Graft-versus-Host Disease

Crohn’s Disease

Others

Stem Cell Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Stem Cell Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Stem Cell Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Adipose-Derived Table 2. Major Company of Cord Blood-Derived Table 3. Major Company of Bone Marrow-Derived Table 4. Major Company of Others Table 5. Global Stem Cell Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global Stem Cell Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Stem Cell Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Stem Cell Drugs Price by Type (2021-2026) & (US$/Unit) Table 11. Global Stem Cell Drugs Sales by Type (2027-2032) & (K Units) Table 12. Global Stem Cell Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Stem Cell Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Stem Cell Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Stem Cell Drugs Price by Type (2027-2032) & (US$/Unit) Table 16. North America Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 17. North America Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 19. Europe Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 23. Latin America Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Stem Cell Drugs Industry Trends Table 27. Stem Cell Drugs Industry Drivers Table 28. Stem Cell Drugs Industry Opportunities and Challenges Table 29. Stem Cell Drugs Industry Restraints Table 30. Global Stem Cell Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Stem Cell Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Stem Cell Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global Stem Cell Drugs Sales Share by Company (2021-2026) Table 34. Global Stem Cell Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Stem Cell Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Stem Cell Drugs Major Company Production Sites and Headquarters Table 37. Global Stem Cell Drugs Company, Product Type & Application Table 38. Global Stem Cell Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Stem Cell Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Stem Cell Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Stem Cell Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Stem Cell Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Stem Cell Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Stem Cell Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Stem Cell Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Stem Cell Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Stem Cell Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Stem Cell Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Stem Cell Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Stem Cell Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Stem Cell Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Stem Cell Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Stem Cell Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Stem Cell Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Stem Cell Drugs Sales by Application (2027-2032) & (K Units) Table 59. Global Stem Cell Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Stem Cell Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Stem Cell Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Stem Cell Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. North America Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 64. North America Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 66. Europe Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 70. Latin America Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Anterogen Company Information Table 74. Anterogen Business Overview Table 75. Anterogen Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Anterogen Stem Cell Drugs Product Portfolio Table 77. Anterogen Recent Development Table 78. Chiesi Pharmaceuticals Company Information Table 79. Chiesi Pharmaceuticals Business Overview Table 80. Chiesi Pharmaceuticals Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Chiesi Pharmaceuticals Stem Cell Drugs Product Portfolio Table 82. Chiesi Pharmaceuticals Recent Development Table 83. CORESTEM, Inc Company Information Table 84. CORESTEM, Inc Business Overview Table 85. CORESTEM, Inc Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. CORESTEM, Inc Stem Cell Drugs Product Portfolio Table 87. CORESTEM, Inc Recent Development Table 88. JCR Pharmaceuticals Co., Ltd Company Information Table 89. JCR Pharmaceuticals Co., Ltd Business Overview Table 90. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Product Portfolio Table 92. JCR Pharmaceuticals Co., Ltd Recent Development Table 93. MEDIPOST Company Information Table 94. MEDIPOST Business Overview Table 95. MEDIPOST Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. MEDIPOST Stem Cell Drugs Product Portfolio Table 97. MEDIPOST Recent Development Table 98. New York Blood Center Company Information Table 99. New York Blood Center Business Overview Table 100. New York Blood Center Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. New York Blood Center Stem Cell Drugs Product Portfolio Table 102. New York Blood Center Recent Development Table 103. Pharmicell Co., Ltd Company Information Table 104. Pharmicell Co., Ltd Business Overview Table 105. Pharmicell Co., Ltd Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Pharmicell Co., Ltd Stem Cell Drugs Product Portfolio Table 107. Pharmicell Co., Ltd Recent Development Table 108. Takeda Company Information Table 109. Takeda Business Overview Table 110. Takeda Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Takeda Stem Cell Drugs Product Portfolio Table 112. Takeda Recent Development Table 113. North America Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. North America Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 115. North America Stem Cell Drugs Sales Market Share by Country (2021-2026) Table 116. North America Stem Cell Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 117. North America Stem Cell Drugs Sales Market Share Forecast by Country (2027-2032) Table 118. North America Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Stem Cell Drugs Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Stem Cell Drugs Market Share by Country (2021-2026) Table 121. North America Stem Cell Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Stem Cell Drugs Market Share Forecast by Country (2027-2032) Table 123. Europe Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Europe Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 125. Europe Stem Cell Drugs Sales Market Share by Country (2021-2026) Table 126. Europe Stem Cell Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 127. Europe Stem Cell Drugs Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Stem Cell Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Stem Cell Drugs Market Share by Country (2021-2026) Table 131. Europe Stem Cell Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Stem Cell Drugs Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 135. Asia-Pacific Stem Cell Drugs Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Stem Cell Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 137. Asia-Pacific Stem Cell Drugs Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Stem Cell Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Stem Cell Drugs Market Share by Country (2021-2026) Table 141. Asia-Pacific Stem Cell Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Stem Cell Drugs Market Share Forecast by Country (2027-2032) Table 143. Latin America Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Latin America Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 145. Latin America Stem Cell Drugs Sales Market Share by Country (2021-2026) Table 146. Latin America Stem Cell Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 147. Latin America Stem Cell Drugs Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Stem Cell Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Stem Cell Drugs Market Share by Country (2021-2026) Table 151. Latin America Stem Cell Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Stem Cell Drugs Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 155. Middle East and Africa Stem Cell Drugs Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Stem Cell Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 157. Middle East and Africa Stem Cell Drugs Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Stem Cell Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Stem Cell Drugs Market Share by Country (2021-2026) Table 161. Middle East and Africa Stem Cell Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Stem Cell Drugs Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Stem Cell Drugs Distributors List Table 166. Stem Cell Drugs Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Stem Cell Drugs Image Figure 2. Global Stem Cell Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stem Cell Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Stem Cell Drugs Sales (2021-2032) & (K Units) Figure 5. Adipose-Derived Image Figure 6. Global Adipose-Derived Sales YoY Growth (2021-2032) & (K Units) Figure 7. Cord Blood-Derived Image Figure 8. Global Cord Blood-Derived Sales YoY Growth (2021-2032) & (K Units) Figure 9. Bone Marrow-Derived Image Figure 10. Global Bone Marrow-Derived Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Stem Cell Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Stem Cell Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Stem Cell Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Stem Cell Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Stem Cell Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Stem Cell Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Stem Cell Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Stem Cell Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Stem Cell Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Stem Cell Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Stem Cell Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Stem Cell Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Stem Cell Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Osteoarthritis Image Figure 28. Global Osteoarthritis Sales YoY Growth (2021-2032) & (K Units) Figure 29. Amyotrophic Lateral Sclerosis Image Figure 30. Global Amyotrophic Lateral Sclerosis Sales YoY Growth (2021-2032) & (K Units) Figure 31. Acute Graft-versus-Host Disease Image Figure 32. Global Acute Graft-versus-Host Disease Sales YoY Growth (2021-2032) & (K Units) Figure 33. Crohn’s Disease Image Figure 34. Global Crohn’s Disease Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Stem Cell Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Stem Cell Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Stem Cell Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Stem Cell Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Stem Cell Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Stem Cell Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Stem Cell Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Stem Cell Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Stem Cell Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Stem Cell Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Stem Cell Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Stem Cell Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Stem Cell Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Stem Cell Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Stem Cell Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Stem Cell Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Stem Cell Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Stem Cell Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Stem Cell Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Stem Cell Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Stem Cell Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Stem Cell Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Stem Cell Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Stem Cell Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Stem Cell Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Stem Cell Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Stem Cell Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Stem Cell Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Stem Cell Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Stem Cell Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Stem Cell Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Stem Cell Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Stem Cell Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Stem Cell Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Adipose-Derived
  • Cord Blood-Derived
  • Bone Marrow-Derived
  • Others
Applications
  • Osteoarthritis
  • Amyotrophic Lateral Sclerosis
  • Acute Graft-versus-Host Disease
  • Crohn’s Disease
  • Others
Companies covered
  • Anterogen
  • Chiesi Pharmaceuticals
  • CORESTEM, Inc
  • JCR Pharmaceuticals Co., Ltd
  • MEDIPOST
  • New York Blood Center
  • Pharmicell Co., Ltd
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Stem Cell Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Stem Cell Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Stem Cell Drugs Market by Type
  6. 1.3.1 Adipose-Derived
  7. 1.3.2 Cord Blood-Derived
  8. 1.3.3 Bone Marrow-Derived
  9. 1.3.4 Others
  10. 1.4 Global Stem Cell Drugs Market Size by Type
  11. 1.4.1 Global Stem Cell Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Stem Cell Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Stem Cell Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Stem Cell Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Stem Cell Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Stem Cell Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Stem Cell Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Stem Cell Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Stem Cell Drugs Industry Trends
  2. 2.2 Stem Cell Drugs Industry Drivers
  3. 2.3 Stem Cell Drugs Industry Opportunities and Challenges
  4. 2.4 Stem Cell Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Stem Cell Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Stem Cell Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Stem Cell Drugs Price (2021-2026)
  4. 3.4 Global Stem Cell Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Stem Cell Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Stem Cell Drugs Company, Product Type & Application
  7. 3.7 Global Stem Cell Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Stem Cell Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Stem Cell Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Stem Cell Drugs Tier 1, Tier 2, and Tier 3
4 Stem Cell Drugs Regional Status and Outlook
  1. 4.1 Global Stem Cell Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Stem Cell Drugs Historic Market Size by Region
  3. 4.2.1 Global Stem Cell Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Stem Cell Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Stem Cell Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Stem Cell Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Stem Cell Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Stem Cell Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Stem Cell Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Stem Cell Drugs by Application
  1. 5.1 Stem Cell Drugs Market by Application
  2. 5.1.1 Osteoarthritis
  3. 5.1.2 Amyotrophic Lateral Sclerosis
  4. 5.1.3 Acute Graft-versus-Host Disease
  5. 5.1.4 Crohn’s Disease
  6. 5.1.5 Others
  7. 5.2 Global Stem Cell Drugs Market Size by Application
  8. 5.2.1 Global Stem Cell Drugs Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Stem Cell Drugs Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Stem Cell Drugs Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Stem Cell Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Stem Cell Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Stem Cell Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Stem Cell Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Stem Cell Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Anterogen
  2. 6.1.1 Anterogen Company Information
  3. 6.1.2 Anterogen Business Overview
  4. 6.1.3 Anterogen Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Anterogen Stem Cell Drugs Product Portfolio
  6. 6.1.5 Anterogen Recent Developments
  7. 6.2 Chiesi Pharmaceuticals
  8. 6.2.1 Chiesi Pharmaceuticals Company Information
  9. 6.2.2 Chiesi Pharmaceuticals Business Overview
  10. 6.2.3 Chiesi Pharmaceuticals Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chiesi Pharmaceuticals Stem Cell Drugs Product Portfolio
  12. 6.2.5 Chiesi Pharmaceuticals Recent Developments
  13. 6.3 CORESTEM, Inc
  14. 6.3.1 CORESTEM, Inc Company Information
  15. 6.3.2 CORESTEM, Inc Business Overview
  16. 6.3.3 CORESTEM, Inc Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CORESTEM, Inc Stem Cell Drugs Product Portfolio
  18. 6.3.5 CORESTEM, Inc Recent Developments
  19. 6.4 JCR Pharmaceuticals Co., Ltd
  20. 6.4.1 JCR Pharmaceuticals Co., Ltd Company Information
  21. 6.4.2 JCR Pharmaceuticals Co., Ltd Business Overview
  22. 6.4.3 JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Product Portfolio
  24. 6.4.5 JCR Pharmaceuticals Co., Ltd Recent Developments
  25. 6.5 MEDIPOST
  26. 6.5.1 MEDIPOST Company Information
  27. 6.5.2 MEDIPOST Business Overview
  28. 6.5.3 MEDIPOST Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 MEDIPOST Stem Cell Drugs Product Portfolio
  30. 6.5.5 MEDIPOST Recent Developments
  31. 6.6 New York Blood Center
  32. 6.6.1 New York Blood Center Company Information
  33. 6.6.2 New York Blood Center Business Overview
  34. 6.6.3 New York Blood Center Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 New York Blood Center Stem Cell Drugs Product Portfolio
  36. 6.6.5 New York Blood Center Recent Developments
  37. 6.7 Pharmicell Co., Ltd
  38. 6.7.1 Pharmicell Co., Ltd Company Information
  39. 6.7.2 Pharmicell Co., Ltd Business Overview
  40. 6.7.3 Pharmicell Co., Ltd Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pharmicell Co., Ltd Stem Cell Drugs Product Portfolio
  42. 6.7.5 Pharmicell Co., Ltd Recent Developments
  43. 6.8 Takeda
  44. 6.8.1 Takeda Company Information
  45. 6.8.2 Takeda Business Overview
  46. 6.8.3 Takeda Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Takeda Stem Cell Drugs Product Portfolio
  48. 6.8.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Stem Cell Drugs Sales by Country
  2. 7.1.1 North America Stem Cell Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Stem Cell Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Stem Cell Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Stem Cell Drugs Market Size by Country
  6. 7.2.1 North America Stem Cell Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Stem Cell Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Stem Cell Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Stem Cell Drugs Sales by Country
  2. 8.1.1 Europe Stem Cell Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Stem Cell Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Stem Cell Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Stem Cell Drugs Market Size by Country
  6. 8.2.1 Europe Stem Cell Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Stem Cell Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Stem Cell Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Stem Cell Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Stem Cell Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Stem Cell Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Stem Cell Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Stem Cell Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Stem Cell Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Stem Cell Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Stem Cell Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Stem Cell Drugs Sales by Country
  2. 10.1.1 South America Stem Cell Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Stem Cell Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Stem Cell Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Stem Cell Drugs Market Size by Country
  6. 10.2.1 South America Stem Cell Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Stem Cell Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Stem Cell Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Stem Cell Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Stem Cell Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Stem Cell Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Stem Cell Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Stem Cell Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Stem Cell Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Stem Cell Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Stem Cell Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Stem Cell Drugs Value Chain Analysis
  2. 12.1.1 Stem Cell Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Stem Cell Drugs Production Mode & Process
  7. 12.2 Stem Cell Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Stem Cell Drugs Distributors
  10. 12.2.3 Stem Cell Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst